A de novo synonymous variant in EFTUD2 disrupts normal splicing and causes mandibulofacial dysostosis with microcephaly: case report.


Journal

BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552

Informations de publication

Date de publication:
17 09 2020
Historique:
received: 12 11 2019
accepted: 03 09 2020
entrez: 18 9 2020
pubmed: 19 9 2020
medline: 3 11 2020
Statut: epublish

Résumé

Mandibulofacial dysostosis with microcephaly (MFDM) is a rare autosomal dominant genetic disease characterized by intellectual and growth retardations, as well as major microcephaly, induced by missense and splice site variants or microdeletions in the EFTUD2 gene. Here, we investigate the case of a young girl with symptoms of MFDM and a normal karyotype. Whole-exome sequencing of the family was performed to identify genetic alterations responsible for this phenotype. We identified a de novo synonymous variant in the EFTUD2 gene. We demonstrated that this synonymous variant disrupts the donor splice-site in intron 9 resulting in the skipping of exon 9 and a frameshift that leads to a premature stop codon. We present the first case of MFDM caused by a synonymous variant disrupting the donor splice site, leading to exon skipping.

Sections du résumé

BACKGROUND
Mandibulofacial dysostosis with microcephaly (MFDM) is a rare autosomal dominant genetic disease characterized by intellectual and growth retardations, as well as major microcephaly, induced by missense and splice site variants or microdeletions in the EFTUD2 gene.
CASE PRESENTATION
Here, we investigate the case of a young girl with symptoms of MFDM and a normal karyotype. Whole-exome sequencing of the family was performed to identify genetic alterations responsible for this phenotype. We identified a de novo synonymous variant in the EFTUD2 gene. We demonstrated that this synonymous variant disrupts the donor splice-site in intron 9 resulting in the skipping of exon 9 and a frameshift that leads to a premature stop codon.
CONCLUSIONS
We present the first case of MFDM caused by a synonymous variant disrupting the donor splice site, leading to exon skipping.

Identifiants

pubmed: 32943010
doi: 10.1186/s12881-020-01121-y
pii: 10.1186/s12881-020-01121-y
pmc: PMC7499997
doi:

Substances chimiques

EFTUD2 protein, human 0
Peptide Elongation Factors 0
Ribonucleoprotein, U5 Small Nuclear 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

182

Subventions

Organisme : Université de Strasbourg
ID : IDEX UNISTRA
Pays : International
Organisme : Agence Nationale de la Recherche
ID : ANR-11-LABX-0070_TRANSPLANTEX
Pays : International

Références

J Biol Chem. 2012 Mar 2;287(10):7374-87
pubmed: 22228759
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Bioinformatics. 2016 Jan 15;32(2):292-4
pubmed: 26428292
Nat Struct Mol Biol. 2008 Nov;15(11):1206-12
pubmed: 18953335
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Clin Dysmorphol. 2006 Jul;15(3):171-4
pubmed: 16760738
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
PLoS One. 2015 Jun 24;10(6):e0130729
pubmed: 26107949
Trends Genet. 2014 Jul;30(7):308-21
pubmed: 24954581
Nat Rev Genet. 2006 Feb;7(2):98-108
pubmed: 16418745
Hum Mutat. 2016 Feb;37(2):148-54
pubmed: 26507355
Genome Res. 2018 Oct;28(10):1442-1454
pubmed: 30143596
Am J Med Genet A. 2009 Dec;149A(12):2762-4
pubmed: 19921636
Cancer Genet Cytogenet. 2002 Apr 15;134(2):175-7
pubmed: 12034536
Am J Med Genet A. 2009 May;149A(5):837-43
pubmed: 19334086
Am J Ophthalmol. 2004 Sep;138(3):504-5
pubmed: 15364249
Nat Rev Genet. 2002 Apr;3(4):285-98
pubmed: 11967553
Genome Biol. 2013 Dec 20;14(12):R143
pubmed: 24359918
Nat Rev Genet. 2011 Aug 31;12(10):683-91
pubmed: 21878961
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Am J Med Genet A. 2007 Jun 1;143A(11):1135-42
pubmed: 17497718

Auteurs

Arthur Jacob (A)

Univ. Lille, CNRS, CHU Lille, Institut Pasteur de Lille, UMR 8199 - EGID, F-59000, Lille, France.

Jennifer Pasquier (J)

Stem Cell and Microenvironment Laboratory, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar.
Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), UMR_S 938, Centre de Recherche Saint-Antoine, Team Cancer Biology and Therapeutics, Institut Universitaire de Cancérologie, Sorbonne Université, F-75012, Paris, France.
Nice Breast institute, 57 bld de la Californie, 06000, Nice, France.

Raphael Carapito (R)

Laboratoire d'ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Université de Strasbourg, 4 rue Kirschleger, 67085, Strasbourg, France.

Frédéric Auradé (F)

INSERM IMRB U955-E10, UPEC - Université Paris Est, Faculté de Médicine, 94000, Créteil, France.

Anne Molitor (A)

Laboratoire d'ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Université de Strasbourg, 4 rue Kirschleger, 67085, Strasbourg, France.

Philippe Froguel (P)

Univ. Lille, CNRS, CHU Lille, Institut Pasteur de Lille, UMR 8199 - EGID, F-59000, Lille, France.
Department of Genomics of Common Disease, School of Public Health, Imperial College, South Kensington Campus, London, SW7 2AZ, UK.

Khalid Fakhro (K)

Epigenetics Cardiovascular Laboratory, Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar.
Department of Human Genetics, Sidra Medical and Research Center, Doha, Qatar.

Najeeb Halabi (N)

Stem cell and microenvironment laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha, Qatar.

Géraldine Viot (G)

Gynécologie Obstétrique, HUPC, Hôpital Cochin, HUPC, Assistance Publique - Hôpitaux de Paris, Paris, France.

Seiamak Bahram (S)

Laboratoire d'ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Université de Strasbourg, 4 rue Kirschleger, 67085, Strasbourg, France.

Arash Rafii (A)

Stem cell and microenvironment laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha, Qatar. jat2021@qatar-med.cornell.edu.
Department Genetic Medicine, Weill Cornell Medical College, New York, NY, USA. jat2021@qatar-med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH